We develop biohardware for blood-based diagnostics that detects bone metastases and bone loss in cancer patients months before they become visible on imaging.
Our vision is to establish biohardware as the foundation for how bone biology is studied, therapies are developed, and diagnostics are designed.
Social media
Target Markets of your organization / Expansion or target markets of your spin-off
SwitzerlandUS
Industry Sector your organization invests in / Industry Sector of your Spin-off